Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scientists make advances in stem-cell-based liver toxicity testing

This article was originally published in Scrip

Executive Summary

A research project involving scientists in the UK and the US has produced liver cells from induced pluripotent stem cells (iPSC) for use in drug toxicity testing. One of the partners in the project, the MRC's Scottish Centre for Regenerative Medicine, is looking to set up a collaboration with researchers in China who recently achieved a similar success.

Topics

UsernamePublicRestriction

Register

SC005154

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel